124P Risk stratification in HR+/HER2- EBC: A comparative study of Prosigna and Oncotype DX with emphasis on menopausal status and lymph node involvementGiulia Cursano, Nicola Fusco, Konstantinos Venetis et al.|ESMO Open|2025Cited by 0